Company Seeks Dismissal Of Investor Claims Over COVID-19 Vaccine Statements
PHILADELPHIA — A biotechnology company and three of its senior executives asked a federal judge in Pennsylvania on Nov. 5 to dismiss shareholder claims that the defendants issued several misrepresentations regarding...To view the full article, register now.
Already a subscriber? Click here to view full article